{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:10:51Z","timestamp":1793380251130,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","jvsvenous.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jvsv.2024.101848","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T16:39:50Z","timestamp":1707583190000},"page":"101848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of acute pulmonary embolism after catheter-directed thrombolysis with dabigatran vs warfarin: Results of a multicenter randomized RE-SPIRE trial"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-7868","authenticated-orcid":false,"given":"Alexander A.","family":"Gostev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"Valiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina A.","family":"Zeidlits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-2140","authenticated-orcid":false,"given":"Evgeniya A.","family":"Shmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya S.","family":"Osipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V.","family":"Cheban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoraan B.","family":"Saaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga L.","family":"Barbarash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Karpenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvsv.2024.101848_bib1","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvsv.2024.101848_bib2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jvsv.2024.101848_bib3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1602172","article-title":"Prevalence of pulmonary embolism among patients hospitalized for syncope","volume":"375","author":"Prandoni","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvsv.2024.101848_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2024.101848_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2021.08.015","article-title":"Pulmonary embolism and deep vein thrombosis: similar but different","volume":"206","author":"Wenger","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvsv.2024.101848_bib6","article-title":"Epidemiology and 3-year outcomes of combined oral contraceptive\u2013associated distal deep vein thrombosis","volume":"4","author":"Galanaud","year":"2020","journal-title":"Res Prac Thromb Haemos"},{"key":"10.1016\/j.jvsv.2024.101848_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvsv.2024.101848_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jth.12521","article-title":"Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial","volume":"12","author":"Kline","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2024.101848_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0002-9149(97)00315-9","article-title":"Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism","volume":"80","author":"Daniels","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvsv.2024.101848_bib10","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvsv.2024.101848_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurheartj\/ehu218","article-title":"Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis","volume":"36","author":"Marti","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvsv.2024.101848_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jvsv.2024.101848_bib13","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A\u00a0prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study","volume":"8","author":"Piazza","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvsv.2024.101848_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1378\/chest.15-0119","article-title":"Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry","volume":"148","author":"Kuo","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2024.101848_bib15","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jvsv.2024.101848_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jvsv.2024.101848_bib17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvsv.2024.101848_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1160\/th15-04-0319","article-title":"Bleeding events with dabigatran or warfarin in patients with venous thromboembolism","volume":"115","author":"Majeed","year":"2016","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jvsv.2024.101848_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.jvsv.2024.101848_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1538-7836.2008.03075.x","article-title":"Warfarin for atrial fibrillation in community-based practise","volume":"6","author":"Rose","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvsv.2024.101848_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvsv.2024.101848_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V124.21.1544.1544","article-title":"Influence of thrombophilia on the efficacy of dabigatran versus warfarin for the extended treatment of acute venous thromboembolism in RE-MEDY\u2122","volume":"124","author":"Schulman","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jvsv.2024.101848_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/clpt.2009.98","article-title":"New antithrombotic drugs","volume":"86","author":"Gross","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jvsv.2024.101848_bib24","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/jth.15449","article-title":"Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: a long-term cross-sectional follow-up of RE-COVER study patients","volume":"19","author":"Wik","year":"2021","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.jvsv.2024.101848_bib25","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1093\/eurheartj\/ehaa247","article-title":"Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial","volume":"41","author":"Boehm","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Journal of Vascular Surgery: Venous and Lymphatic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X24001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X24001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:09:52Z","timestamp":1729213792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X24001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2213333X24001355"],"URL":"https:\/\/doi.org\/10.1016\/j.jvsv.2024.101848","relation":{},"ISSN":["2213-333X"],"issn-type":[{"value":"2213-333X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of acute pulmonary embolism after catheter-directed thrombolysis with dabigatran vs warfarin: Results of a multicenter randomized RE-SPIRE trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery: Venous and Lymphatic Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvsv.2024.101848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"101848"}}